From HAE Armenia

We are extremely happy to announce that the study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in patients with congenital C1-INH deficiency is now open at the Heratsi Hospital in Yerevan. This study is the opportunity for HAE patients to access a modern investigational treatment option, and hopefully, more clinical studies in Hereditary Angioedema in Armenia will be followed.